During the RSNA 2020 virtual conference, USARAD announced the issuance of a new utility patent. The new patent will allow the leading U.S. Joint Commission Accredited teleradiology and telemedicine company to expand its innovative Radiology-as-a-Service (RAAS) model that optimizes the power of Artificial Intelligence and Blockchain to provide the highest quality service in telemedicine for affordable prices.
USPTO issued patent # US10,803,985, “Method of facilitating Imaging Study Interpretations between Healthcare Facilities and Physicians Including Customization of Imaging Studies” on October 13, 2020. The patent, which was filed 2 years prior, is assigned to its partner, MDW.io, licensed to USARAD Holdings, and is a part of a patent portfolio with multiple additional pending patents.
Dr. Michael Yuz, USARAD’s founder & CEO, as well as one of the inventors of the above mentioned patent, stated: “We are indeed entering an exciting time in USARAD 12-year history. By bundling new technologies with low cost radiology devices via RAAS model, including those powered by Nano-x’ disruptive digital x-ray source (pending FDA approval), demonstrated at RSNA 2020, we are bringing unprecedented efficiencies to deliver faster, cheaper and better healthcare.”
It is through the pursuit of continuously advancing their Radiology-as-a-Service technology that USARAD has maintained a top position in the field of telehealth and teleradiology, and continues to attract the top talent of American Board-Certified doctors to help provide impeccable service to patients around the world.
